|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 645981-645990 of 2348419 (234842 Page(s) Totally)
<< < 64594 64595 64596 64597 64598 64599 64600 64601 64602 64603 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-03-06T03:41:13Z |
Overcoming the digital divide: Computer access and use among the differently-abled elderly in Mainland China
|
Gan, X.;Wang, K.H.;Liu, L.;Tuan, P.-C.;Chen, H.-G.;Chen, G.; Gan, X.; Wang, K.H.; Liu, L.; Tuan, P.-C.; Chen, H.-G.; Chen, G.; HOUN-GEE CHEN |
| 臺大學術典藏 |
2021-11-03T01:38:38Z |
Overcoming the energy gap law in near-infrared OLEDs by exciton-vibration decoupling
|
Wei, YC; Wang, SF; Hu, Y; Liao, LS; Chen, DG; Chang, KH; Wang, CW; Liu, SH; Chan, WH; Liao, JL; Hung, WY; Wang, TH; Chen, PT; Hsu, HF; Chi, Y; Chou, PT; PI-TAI CHOU |
| 淡江大學 |
2020-06-29 |
Overcoming the energy gap law in near-infrared OLEDs by exciton–vibration decoupling
|
Wei, Yu-Chen;Wang, Sheng Fu;Hu, Yun;Liao, Liang-Sheng;Chen, Deng-Gao;Chang, Kai-Hsin;Wang, Chi-Wei;Liu, Shih-Hung;Chan, Wei-Hsiang;Liao, Jia-Ling;Hung, Wen-Yi;Wang, Tsai-Hui;Chen, Po-Ting;Hsiu-Fu Hsu, Yun Chi;Chou, Pi-Tai |
| 臺大學術典藏 |
2022-09-15T01:08:48Z |
Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia—Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium
|
Shimizu T.; Kim D.-W.; Loong H.H.; Chia-Chi Lin; Ng M.C.H.; Yamamoto N.; Ma B.; Tan D.S.W. |
| 國立臺灣海洋大學 |
2011-10 |
OVERCOMING THE NEGATIVE FREQUENCIES - INSTANTANEOUS FREQUENCY AND AMPLITUDE ESTIMATION USING OSCULATING CIRCLE METHOD
|
Ming-Kuang Hsu; Jiun-Chyuan Sheu; Cesar Hsue |
| 中國醫藥大學 |
2006-11 |
Overcoming Trastuzumab Resistance in HER2-Overexpressing Breast Cancer Cells by Using a Novel Celecoxib-Derived PDK-1 Inhibito
|
(Ping-Hui Tseng); (Shu-Chuan Weng); (Yu-Chieh Wang); 翁靖如(Jing-Ru Weng); (Chang-Shi Chen); (Robert W. Brueggemei); (Charles L. Shapiro); 陳慶宇(Ching-Yu Chen); (Michael Pollak); (Ching-Shih Chen*)* |
| 國家衛生研究院 |
2006-11 |
Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor
|
Tseng, PH; Wang, YC; Weng, SC; Weng, JR; Chen, CS; Brueggemeier, RW; Shapiro, CL; Chen, CY; Dunn, SE; Pollak, M; Chen, CS |
| 國立臺灣大學 |
2006 |
Overcoming Trastuzumab Resistance in HER2-Overexpressing Breast Cancer Cells by Using a Novel Celecoxib-Derived Phosphoinositide-Dependent Kinase-1 Inhibitor
|
Tseng, Ping-Hui; Wang, Yu-Chieh; Weng, Shu-Chuan; Weng, Jing-Ru; Chen, Chang-Shi; Brueggemeier, Robert W.; Shapiro, Charles L.; Chen, Ching-Yu; Dunn, Sandra E.; Pollak, Michael; Chen, Ching-Shih |
| 臺大學術典藏 |
2006 |
Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor
|
CHING-YU CHEN; Tseng, P.-H.;Wang, Y.-C.;Weng, S.-C.;Weng, J.-R.;Chen, C.-S.;Brueggemeier, R.W.;Shapiro, C.L.;Chen, C.-Y.;Dunn, S.E.;Pollak, M.;Chen, C.-S. |
| 國家衛生研究院 |
2020-07-07 |
Overcoming vincristine resistance in cancer: Computational design and discovery of piperine-inspired P-glycoprotein inhibitors
|
Syed, SB;Lin, SY;Arya, H;Fu, IH;Yeh, TK;Charles, MRC;Periyasamy, L;Hsieh, HP;Coumar, MS |
Showing items 645981-645990 of 2348419 (234842 Page(s) Totally)
<< < 64594 64595 64596 64597 64598 64599 64600 64601 64602 64603 > >>
View [10|25|50] records per page
|
